Cognitive Efficacy of Pharmacologic Treatments in Multiple Sclerosis: A Systematic Review

ConclusionsHigher-quality randomized controlled trials are needed to establish the cognitive efficacy of pharmacologic treatments for MS-related cognitive dysfunction, with cognition as the primary endpoint. Researchers are urged to use standardized criteria (such as the AAN criteria) to guide their research designs. Clinicians should consider effect sizes of studies before deciding whether to prescribe certain medications to ameliorate cognitive symptoms.
Source: CNS Drugs - Category: Neurology Source Type: research